Dyslipidemia Market is Anticipated to Accelerate in the Coming 10 Years Due to the Development of New Classes of Drugs, Such as CETP Inhibitors and Gene-based Therapies | DelveInsight
The dyslipidemia market is expected to witness significant growth, driven by an aging population, increasing awareness of cardiovascular health, and…
